Exhibit 10.1
PLURISTEM THERAPEUTICS INC.
Subscription Agreement
for Common Stock and Warrants
Pluristem Therapeutics Inc.
MATAM Advanced Technology Park # 20 Haifa 31905, Israel
Ladies and Gentlemen:
1.
Subscription .
The undersigned (the “ Investor ”) hereby agrees
to purchase units (“ Units ”) of the securities
of Pluristem Therapeutics, Inc. (“ Pluristem ”
or the “ Company ”) consisting of: (i) shares of
Common Stock (“ Common Shares ”) and Warrants to
purchase shares of Common Stock at an exercise price of $1.90 per
share (the “ Warrants ”) for the aggregate
dollar amount set forth on the signature page hereto. The purchase
price per Unit is $1.16. The Common Shares, the Warrants and the
shares of Common Stock issuable upon exercise of the Warrants
(“ Warrant Shares ”) are referred to herein as
the “ Securities .”
THE INVESTOR UNDERSTANDS THAT AN
INVESTMENT IN THE SECURITIES INVOLVES A HIGH DEGREE OF RISK, AND
THAT THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND
RESALE. THERE CAN BE NO ASSURANCES THAT THE INVESTOR WILL RECOVER
ALL OR ANY PORTION OF THIS INVESTMENT.
2.
Execution and Acceptance of Subscription Agreement . Upon
the execution hereof by the Investor and full payment of the
purchase price for the Units, subject to acceptance by Pluristem,
Pluristem will issue to the Investor the Units subscribed for by
the Investor. The Company has the absolute right to accept or
reject this subscription.
3.
Access to Information; Independent Investigation . The
Investor hereby acknowledges that:
|
a.
No offering memorandum or
similar disclosure document has been prepared in connection with
the sale of the Units. The Investor has read this Subscription
Agreement and is familiar with the terms of the
Securities.
|
|
b.
In making the decision to
purchase the Securities, the Investor and the Investor’s
advisors have, prior to any sale to the Investor, been given access
and the opportunity to examine all books and records of Pluristem,
all contracts and documents relating to Pluristem, and all filings
made by Pluristem with the U.S. Securities and Exchange Commission,
and an opportunity to ask questions of, and to receive answers
from, Pluristem and to obtain any additional information necessary
to verify the accuracy of the information provided to the Investor.
The Investor and the Investor’s advisors have been furnished
with all materials relating to the business, finances and
operations of Pluristem and materials relating to the offer and
sale of the Securities that have been requested.
|
|
c.
The only representations
and warranties being given to the Investor by Pluristem are as
contained in this Subscription Agreement.
|
1
4.
Investment Representations .
|
a.
The Investor understands
that the Securities are being offered and sold in reliance upon
certain exemptions from the registration provisions of the
Securities Act of 1933, as amended (the “Securities
Act ”), and non-public offering exemptions of the
securities acts of the states in which the Shares may be offered or
sold. As a condition to purchasing the Units and becoming an
investor in Pluristem, for the purposes (among others) of the
above-mentioned exemptions and qualifications to the extent
applicable, and knowing that Pluristem will rely upon the
statements made herein for such exemptions and in determining the
Investor’s suitability as an investor, the Investor
represents and warrants as follows:
|
|
b.
Risks Associated with
Investment in the Company . The Investor has been advised that
the Investor must be prepared to bear the economic risk of an
investment in Pluristem for an indefinite period because the
Securities are not registered under the Securities Act. The
Investor has read the various risk factors described under the
heading “Risk Factors” in Part I, Item 1A, in the
Company’s annual report on Form 10-K for the fiscal year
ended June 30, 2008.
|
|
c.
Experience of Such
Investor . The Investor, either alone or together with its
representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating
the merits and risks of the prospective investment in the
Securities, and has so evaluated the merits and risks of such
investment. The Investor is able to bear the economic risk of an
investment in the Securities (and each part thereof) and, at the
present time, is able to afford a complete loss of such
investment.
|
|
d.
Purchase for Own
Account . The Investor represents that it is acquiring the
Securities as principal for its own account for investment purposes
only and not and will not acquire the Common Shares, the Warrants
or the Warrant Shares with a view to or for distributing or
reselling them in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any
of them in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or
understandings with any other persons to distribute or regarding
their distribution of such Securities. The Investor understands
that the Securities included therein are “restricted
securities” and have not been registered under the Securities
Act or any applicable state securities laws. The Investor is
acquiring the Securities and each part thereof hereunder in the
ordinary course of its business.
|
|
e.
Further
Representations . The Investor further represents and warrants
that:
|
|
|
(1)
|
The funds to be
tendered as payment for the Units will not represent funds borrowed
by the Investor;
|
|
|
(2)
|
The Investor
agrees not to reproduce, copy or otherwise distribute or make any
use of the information and confidential information of Pluristem
(other than the Investor’s legal and tax
advisors);
|
|
|
(A)
|
If not an
individual, was not formed for the specific purpose of acquiring
the Units.
|
|
|
(B)
|
If not an
individual, is duly organized, validly existing and in good
standing under the laws of its state of organization.
|
|
|
(C)
|
Has full power
to execute, deliver and perform this Subscription
Agreement;
|
|
|
(4)
|
The execution,
delivery and performance of this Subscription Agreement by the
Investor, and the consummation by the Investor of the transaction
contemplated hereby, have been duly authorized by all necessary
corporate or other action. This Subscription Agreement has been
duly executed and delivered by the Investor and constitutes a valid
and binding obligation of the Investor, enforceable in accordance
with its terms;
|
2
|
|
(5)
|
If the Investor
is not an individual, the execution of and performance of the
transactions contemplated by this Subscription Agreement and
compliance with their provisions by the Investor will not violate
any provision of law and will not conflict with or result in any
breach of any of the terms, conditions, or provisions of, or
constitute a default under, or require a consent or waiver under,
its organizational documents (each as amended to date and presently
in effect) or any indenture, lease, agreement, or other instrument
to which the Investor is a party or by which it or any of its
properties is bound, or any decree, judgment, order, statute, rule
or regulation applicable to the Investor; and
|
|
|
(6)
|
No consent,
approval, order, or authorization of, or registration,
qualification, designation, declaration, or filing with, any
governmental authority is required on the part of the Investor in
connection with the execution and delivery of this Subscription
Agreement, or the offer, sale, and delivery of the Units, as
contemplated by this Subscription Agreement.
|
6.
Securities Law Matters .
a.
Publicity . The parties agree t
|